Amit Kalimi

Wavelength Pharmaceuticals Ltd. develops and markets active pharmaceutical ingredients. The firm specializes in manufacturing cytotoxic, steroid and high potency and core competency in complex chemistries. It develops generic APIs and finished dose forms for a blue-chip customer base. The company is headquartered in Jerusalem, Israel.

Wavelength Pharmaceuticals Ltd. develops and markets active pharmaceutical ingredients. The firm specializes in manufacturing cytotoxic, steroid and high potency and core competency in complex chemistries. It develops generic APIs and finished dose forms for a blue-chip customer base. The company is headquartered in Jerusalem, Israel.

Wavelength Pharmaceuticals Ltd. develops and markets active pharmaceutical ingredients. The firm specializes in manufacturing cytotoxic, steroid and high potency and core competency in complex chemistries. It develops generic APIs and finished dose forms for a blue-chip customer base. The company is headquartered in Jerusalem, Israel.

Wavelength Pharmaceuticals Ltd. develops and markets active pharmaceutical ingredients. The firm specializes in manufacturing cytotoxic, steroid and high potency and core competency in complex chemistries. It develops generic APIs and finished dose forms for a blue-chip customer base. The company is headquartered in Jerusalem, Israel.

Wavelength Pharmaceuticals Ltd. develops and markets active pharmaceutical ingredients. The firm specializes in manufacturing cytotoxic, steroid and high potency and core competency in complex chemistries. It develops generic APIs and finished dose forms for a blue-chip customer base. The company is headquartered in Jerusalem, Israel.